Medicare Enrolled

Karen Moses, NP-C

Nurse Practitioner - Adult Health · Savannah, GA
4700 WATERS AVE, Savannah, GA 31404
9123546187
Registered in NPPES since 2007
NPI: 1093999054 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Moses from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Moses? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Moses

Karen Moses is a nurse practitioner - adult health in Savannah, GA, with 18 years of NPI registration.

Between the years covered by Open Payments, Moses received a total of $9,308 from 63 pharmaceutical and/or device companies across 412 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Moses is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration $9,308 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,308
Total received (2021-2024)
Avg $2,327/year across 4 years
Top 3% in GA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
412
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,750
2023
$2,090
2022
$2,542
2021
$1,927

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$237
Merck Sharp & Dohme LLC
$234
PFIZER INC.
$211
Incyte Corporation
$178
Janssen Biotech, Inc.
$161
ABBVIE INC.
$141
Regeneron Healthcare Solutions, Inc.
$140
Astellas Pharma US Inc
$137
AstraZeneca Pharmaceuticals LP
$112
Genentech USA, Inc.
$106
E.R. Squibb & Sons, L.L.C.
$102
Eisai Inc.
$82
Bayer Healthcare Pharmaceuticals Inc.
$81
Alexion Pharmaceuticals, Inc.
$78
Takeda Pharmaceuticals U.S.A., Inc.
$74
Daiichi Sankyo Inc.
$70
GlaxoSmithKline, LLC.
$62
Lilly USA, LLC
$52
Pharmacosmos Therapeutics Inc.
$52
Ipsen Biopharmaceuticals, Inc
$47
Acrotech Biopharma Inc.
$47
Aveo Pharmaceuticals, Inc.
$37
Gilead Sciences, Inc.
$35
ADC Therapeutics America, Inc.
$34
Deciphera Pharmaceuticals Inc.
$33
Rigel Pharmaceuticals, Inc.
$33
Stemline Therapeutics Inc.
$28
TAIHO ONCOLOGY, INC.
$28
EMD Serono, Inc.
$22
Karyopharm Therapeutics Inc.
$21
SERVIER PHARMACEUTICALS LLC
$20
BeiGene USA, Inc.
$19
JAZZ PHARMACEUTICALS INC.
$18
PUMA BIOTECHNOLOGY, INC.
$18
Top 3 companies account for 24.8% of 2024 payments
All-time payments by company (2021-2024) ›
Merck Sharp & Dohme LLC
$565
AstraZeneca Pharmaceuticals LP
$537
Novartis Pharmaceuticals Corporation
$490
Amgen Inc.
$490
Astellas Pharma US Inc
$478
Seagen Inc.
$445
PFIZER INC.
$412
Regeneron Healthcare Solutions, Inc.
$390
Janssen Biotech, Inc.
$379
Celgene Corporation
$361
E.R. Squibb & Sons, L.L.C.
$285
Genentech USA, Inc.
$282
Incyte Corporation
$264
Lilly USA, LLC
$261
Takeda Pharmaceuticals U.S.A., Inc.
$254
GENZYME CORPORATION
$238
Eisai Inc.
$214
Daiichi Sankyo Inc.
$185
ABBVIE INC.
$178
Alexion Pharmaceuticals, Inc.
$168
Bayer Healthcare Pharmaceuticals Inc.
$160
G1 Therapeutics, Inc.
$137
Adaptive Biotechnologies Corporation
$134
Rigel Pharmaceuticals, Inc.
$133
Karyopharm Therapeutics Inc.
$131
Exelixis Inc.
$129
Epizyme, Inc.,
$121
Ipsen Biopharmaceuticals, Inc
$118
GlaxoSmithKline, LLC.
$112
BeiGene USA, Inc.
$87
Acrotech Biopharma Inc.
$83
JAZZ PHARMACEUTICALS INC.
$83
TAIHO ONCOLOGY, INC.
$60
Merck Sharp & Dohme Corporation
$55
Gilead Sciences, Inc.
$54
Pharmacosmos Therapeutics Inc.
$52
PUMA BIOTECHNOLOGY, INC.
$51
Kite Pharma, Inc.
$51
EISAI INC.
$49
Stemline Therapeutics Inc.
$47
Deciphera Pharmaceuticals Inc.
$45
Pharmacyclics LLC, an AbbVie Company
$38
Aveo Pharmaceuticals, Inc.
$37
CTI BioPharma Corp.
$36
Mylan Institutional Inc.
$36
AVEO Pharmaceuticals, Inc.
$35
ADC Therapeutics America, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Taiho Oncology, Inc.
$24
EMD Serono, Inc.
$22
Pharmacyclics LLC, An AbbVie Company
$22
TerSera Therapeutics LLC
$21
Sobi, Inc
$21
SERVIER PHARMACEUTICALS LLC
$20
Acrotech Biopharma LLC
$20
AMAG Pharmaceuticals, Inc.
$19
Octapharma USA, Inc.
$19
Agios Pharmaceuticals, Inc.
$18
GE HealthCare
$18
ARRAY BIOPHARMA INC
$16
NESTLE HEALTHCARE NUTRITION INC.
$14
AbbVie Inc.
$13
Top 3 companies account for 17.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Aliqopa · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Columvi · DARZALEX · DOPTELET · ELITEK · ELZONRIS · ENHERTU · EPKINLY · ERLEADA · Enhertu · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Rezlidhia · SARCLISA · SCEMBLIX · Somatuline Depot · Stivarga · TAGRISSO · TAZVERIK · TUKYSA · Tavalisse · Tibsovo · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Venclexta · Vonjo · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Savannah?
Compare adult-health nurse practitioners in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
55
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
SAVANNAH HEALTH SERVICES LLC DBA MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Moses is a nurse practitioner - adult health, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Moses receive payments from pharmaceutical companies?
Yes. Moses received a total of $9,308 from 63 companies across 412 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Moses) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Adult-Health Nurse Practitioners in Savannah
Browse adult-health nurse practitioners in Savannah ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in GA
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in GA
Which GA adult-health nurse practitioners receive the most from drug and device companies.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →